Summary
- Current Price
- As of today, VRCA price is $7.37, up +3.08% on
- Current Price All-Time High
- VRCA price is currently -96.84% below its historical high of $232.90 set on
- Market Cap
- VRCA current market cap is $127M, up +155.86% over the past 365 days
- PE Ratio
- VRCA PE ratio is unknown
- Revenue
- VRCA current annual revenue is $35.58M, up +370.22% year-over-year
- Next Earnings
- As of today, the next earnings release for VRCA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Verrica Pharmaceuticals Inc. |
| Ticker | NASDAQ: VRCA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | verrica.com |
| Employees | 71 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $7.37 | ||
| Price, 1D Change | +3.08% | |
| $127M | ||
| - | ||
| - | ||
| 2.27 | ||
| $36M | ||
| Revenue, 1Y Change | +370.22% | |
| -$1.68 | ||
| EPS, 1Y Change | +88.64% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.68 | ||
| EPS Estimate | N/A | -$2.08 |
| EPS Est. Change | N/A | -23.58% |
| $35.58M | ||
| Revenue Estimate | N/A | $24.83M |
| Revenue Est. Change | N/A | -30.21% |
| $7.37 | ||
| Price Target | - | $18.00 |
| Price Tgt. Change | - | +144.23% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.40 | -$14.78 | -952.79% | |
| -$0.43 | -$1.68 | -295.08% | |
| -$2.08 | N/A | -23.58% | |
| -$1.71 | N/A | -1.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.25M | $7.57M | -8.34% | |
| $35.00M | $35.58M | +1.66% | |
| $24.83M | N/A | -30.21% | |
| $45.35M | N/A | +27.47% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +37.76% | ||
| -88.02% | ||
| +155.86% | ||
| -50.81% | ||
| +370.22% | ||
| +293.90% | ||
| +88.64% | ||
| -134.25% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $7.37 | ||
| $5.90 | ||
| SMA 200 vs Price | -19.89% | |
| $6.06 | ||
| SMA 50 vs Price | -17.81% | |
| 2.27 | ||
| $0.63 | ||
| 57.78 | ||
| 124.95% | ||
| 101.95% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $35.58M | ||
| -$1.68 | ||
| $32.14M | ||
| 90.33% | ||
| -$11.94M | ||
| -33.56% | ||
| -$17.89M | ||
| -50.27% | ||
| -$11.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.07 | ||
| 2.47 | ||
| 2.33 | ||
| - | ||
| 5 | ||
| -5.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 3.56 | ||
| 5.12 | ||
| -8.79 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $24.74M | ||
| $30.15M | ||
| $47.52M | ||
| $40.58M | ||
| $22.78M | ||
| $16.44M | ||
| $1.63M | ||
| $746.00K | ||
| $2.07M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $53.46M | ||
| $44.08M | ||
| $3.44M | ||
| $0.00 | ||
| $781.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$17.74M | ||
| $0.00 | ||
| $1.56M | ||
| $0.00 | ||
| -$17.74M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Brookline Capital | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| Needham | ||
| TD Cowen | → |
Analyst sentiment
Institutional ownership
Screeners with VRCA
FAQ
What is the ticker symbol for Verrica Pharmaceuticals Inc.?
The ticker symbol for Verrica Pharmaceuticals Inc. is NASDAQ:VRCA
Does Verrica Pharmaceuticals Inc. pay dividends?
No, Verrica Pharmaceuticals Inc. does not pay dividends
What sector is Verrica Pharmaceuticals Inc. in?
Verrica Pharmaceuticals Inc. is in the Healthcare sector
What industry is Verrica Pharmaceuticals Inc. in?
Verrica Pharmaceuticals Inc. is in the Biotechnology industry
What country is Verrica Pharmaceuticals Inc. based in?
Verrica Pharmaceuticals Inc. is headquartered in United States
When did Verrica Pharmaceuticals Inc. go public?
Verrica Pharmaceuticals Inc. initial public offering (IPO) was on June 15, 2018
Is Verrica Pharmaceuticals Inc. in the S&P 500?
No, Verrica Pharmaceuticals Inc. is not included in the S&P 500 index
Is Verrica Pharmaceuticals Inc. in the NASDAQ 100?
No, Verrica Pharmaceuticals Inc. is not included in the NASDAQ 100 index
Is Verrica Pharmaceuticals Inc. in the Dow Jones?
No, Verrica Pharmaceuticals Inc. is not included in the Dow Jones index
When was Verrica Pharmaceuticals Inc. last earnings report?
Verrica Pharmaceuticals Inc.'s most recent earnings report was on May 12, 2026
When does Verrica Pharmaceuticals Inc. report earnings?
The date for Verrica Pharmaceuticals Inc.'s next earnings report has not been announced yet
Data Sources & References
- VRCA Official Website www.verrica.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1660334/000166033426000008/0001660334-26-000008-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1660334/000166033426000008/0001660334-26-000008-index.htm
- VRCA Profile on Yahoo Finance finance.yahoo.com/quote/VRCA
- VRCA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrca